Literature DB >> 32245701

Is traditional Chinese medicine useful in the treatment of COVID-19?

Kai Zhang1.   

Abstract

Entities:  

Keywords:  COVID-19; Comment; Traditional Chinese medicine

Mesh:

Substances:

Year:  2020        PMID: 32245701      PMCID: PMC7138187          DOI: 10.1016/j.ajem.2020.03.046

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


× No keyword cloud information.
Recently, there have been many controversies around the world about the treatment of coronavirus disease 2019 (COVID-19). As a traditional Chinese medicine (TCM) practitioner, I think that the TCM treatment of COVID-19 is ignored. On Feb 6, 2020, the guideline for rapid advice on diagnosis and treatment of 2019-nCoV pneumonia has been released in China [1]. For the treatment of COVID-19, the guideline recommended using routine treatment plus TCM. Routine treatment mainly includes the use of antiviral and antibiotic drugs, providing nutritional support, and giving mechanical ventilation when necessary and so on. As far as I know, since December 2019, the majority of COVID-19 patients in China have been treated with integrated Chinese and Western medicine. Hundreds of herbs have been used throughout the country. Most Chinese herbal medicines can be divided into three categories: clearing heat, eliminating dampness and detoxification. At the Eighth People's Hospital of Guangzhou, China, doctors found that 50 patients with mild COVID-19 were treated with Toujie Quwen granule, and all patients returned to normal temperature after 1 week, their overall symptoms improved significantly, without any serious symptoms. It was found that this drug significantly improved the clinical symptoms caused by COVID-19 and had a tendency to reduce the occurrence of severe pneumonia [2].Recently, 4 provincial hospitals in China used Qingfei Paidu decoction to treat 214 patients with COVID-19, taking 3 days as a course of treatment, and the total effective rate reached more than 90%. Among them, the symptoms and imaging performance of 60% of patients improved significantly. 30% of patients have smooth symptoms without exacerbation [3]. Despite there are some methodological problems in these studies, such as no control groups, no mention of randomization, lack of blinding and allocation concealment designs, unclear evaluation indicators, and lack of long-term efficacy and follow-up, but considering the urgency of patients' treatment need, large-scale randomized controlled studies are almost impossible and involve ethical issues. There is no high-quality evidence for the safety of some Chinese herbs, but when used correctly, it is generally believed that there are no serious adverse reactions [4]. In veiw of the current evidence for the treatment of COVID-19 mainly comes from in vitro cell tests, animal experiments, and data mining, the level of evidence for the effectiveness of TCM research is relatively high, because it is clinical and real-world studies.

Funding

No funding was received.

Declaration of competing interest

The author has no conflicts of interest or financial ties to disclose.
  12 in total

Review 1.  The important role of polysaccharides from a traditional Chinese medicine-Lung Cleansing and Detoxifying Decoction against the COVID-19 pandemic.

Authors:  Peng Cao; Sanlan Wu; Tingting Wu; Yahui Deng; Qilin Zhang; Kaiping Wang; Yu Zhang
Journal:  Carbohydr Polym       Date:  2020-04-22       Impact factor: 9.381

Review 2.  Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms.

Authors:  Kai Huang; Pan Zhang; Zhenghao Zhang; Ji Youn Youn; Chen Wang; Hongchun Zhang; Hua Cai
Journal:  Pharmacol Ther       Date:  2021-03-31       Impact factor: 13.400

3.  In Silico Screening of Potential Spike Glycoprotein Inhibitors of SARS-CoV-2 with Drug Repurposing Strategy.

Authors:  Tian-Zi Wei; Hao Wang; Xue-Qing Wu; Yi Lu; Sheng-Hui Guan; Feng-Quan Dong; Chen-le Dong; Gu-Li Zhu; Yu-Zhou Bao; Jian Zhang; Guan-Yu Wang; Hai-Ying Li
Journal:  Chin J Integr Med       Date:  2020-08-01       Impact factor: 1.978

Review 4.  Current updates on the European and WHO registered clinical trials of coronavirus disease 2019 (COVID-19).

Authors:  Henu Kumar Verma; Neha Merchant; Manish Kumar Verma; Cansu İlke Kuru; Anand Narayan Singh; Fulden Ulucan; Poonam Verma; Antaripa Bhattacharya; L V K S Bhaskar
Journal:  Biomed J       Date:  2020-07-24       Impact factor: 4.910

5.  The scientific literature on Coronaviruses, COVID-19 and its associated safety-related research dimensions: A scientometric analysis and scoping review.

Authors:  Milad Haghani; Michiel C J Bliemer; Floris Goerlandt; Jie Li
Journal:  Saf Sci       Date:  2020-05-07       Impact factor: 6.392

6.  Opportunities and challenges of traditional Chinese medicine going abroad for COVID-19 treatment.

Authors:  Xiao-Qing Huang; Meng-Yun Zhou; Yong-Ran Cheng; Lan Ye; Ming-Wei Wang; Juan Chen; Li-Jun Zhao; Zhan-Hui Feng
Journal:  Am J Emerg Med       Date:  2020-06-06       Impact factor: 2.469

7.  Chinese herbal medicine reduces mortality in patients with severe and critical Coronavirus disease 2019: a retrospective cohort study.

Authors:  Guohua Chen; Wen Su; Jiayao Yang; Dan Luo; Ping Xia; Wen Jia; Xiuyang Li; Chuan Wang; Suping Lang; Qingbin Meng; Ying Zhang; Yuhe Ke; An Fan; Shuo Yang; Yujiao Zheng; Xuepeng Fan; Jie Qiao; Fengmei Lian; Li Wei; Xiaolin Tong
Journal:  Front Med       Date:  2020-09-14       Impact factor: 4.592

8.  Acupuncture for breathlessness in COVID-19: A protocol for systematic review and meta-analysis.

Authors:  Baozhen Zhang; Kai Zhang; Qilin Tang; Kaihang Sun; Zhenzhen Han
Journal:  Medicine (Baltimore)       Date:  2020-07-02       Impact factor: 1.817

9.  Chinese herbal medicine for COVID-19: Current evidence with systematic review and meta-analysis.

Authors:  Arthur Yin Fan; Sherman Gu; Sarah Faggert Alemi
Journal:  J Integr Med       Date:  2020-07-31

10.  Acupuncture and related interventions for anxiety in coronavirus disease 2019: A protocol for systematic review and meta-analysis.

Authors:  Haowen Jia; Zhenzhen Han; Kai Zhang; Qilin Tang; Kaihang Sun; Hongwen Huang; Feng Qi
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.